Alterity reports data from multiple system atrophy study
Source: SeekingAlpha
2025-07-28 10:33:10 ET
More on Alterity Therapeutics
- Seeking Alpha’s Quant Rating on Alterity Therapeutics
- Historical earnings data for Alterity Therapeutics
- Financial information for Alterity Therapeutics
Read the full article on Seeking Alpha
For further details see:
Alterity reports data from multiple system atrophy study
Alterity Therapeutics Limited
NASDAQ: ATHE
ATHE Trading
0.17% G/L:
$3.57 Last:
3,239 Volume:
$3.58 Open:
ATHE Latest News
March 09, 2026 07:25:00 am
Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit
March 04, 2026 07:25:00 am
Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor
March 02, 2026 07:25:00 am
Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments
January 30, 2026 07:25:00 am
Alterity Therapeutics: Appendix 4C - Q2 FY26 Quarterly Cash Flow Report & Corporate Update
ATHE Stock Data
$54,331,623
14,397,880
N/A
9
N/A
Biotechnology & Life Sciences
Healthcare
AU
Melbourne
